miRagen Therapeutics was founded in 2007 to improve patients’ lives by developing innovative microRNA (miRNA) based therapeutics for the treatment of cardiovascular and muscle disease. miRNAs, a recently discovered class of small RNAs encoded in the genome ... [more]
Even with our current understanding of molecular mechanisms, cardiovascular disease (CVD) remains the primary cause of morbidity and mortality in the industrialized ... [more]
miRagen believes that through cooperation and teamwork we can make a difference. Together, we created our mission and vision statements to reflect our commitment to you. ... [more]
At miRagen, our staff members have a true passion for innovative science. We believe that hiring the brightest, most talented individuals will help us fulfill our mission to create breakthrough ... [more]
